Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LIQLW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HuCL47-B1
|
|||||
| Synonyms |
HuCL47-B1
Click to Show/Hide
|
|||||
| Organization |
ADC THERAPEUTICS SA | MEDIMMUNE LIMITED
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
HuCL47
|
Antibody Info | ||||
| Antigen Name |
Interleukin-13 receptor subunit alpha-2 (IL13RA2)
|
Antigen Info | ||||
| Payload Name |
B4 Payload
|
Payload Info | ||||
| Therapeutic Target |
Deoxyribonucleic acid (DNA)
|
Target Info | ||||
| Linker Name |
US20230285580A1 B12-B2 linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
B1
|
|||||